FDA Inspection 1102160 - Invitrx Therapeutics - September 18, 2019

Record Details

This FDA Inspection record concerns Invitrx Therapeutics, with an inspection on September 18, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Invitrx Therapeutics
Inspection Date: September 18, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · dd37ec49-37b7-4de9-8aae-f06c5ac90aa5

Violation Codes8

21 CFR 211.113(b)21 CFR 211.130(b)21 CFR 211.18821 CFR 211.188(b)21 CFR 211.25(a)21 CFR 211.42(c)(10)21 CFR 211.42(c)(10)(iv)21 CFR 211.67(b)(6)

Full citation text and observation details available on the Dashboard.